CUSIP: G1110E107
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
131,883,808
-
Total 13F shares
-
62,449,262
-
Share change
-
+41,782,064
-
Total reported value
-
$868,331,200
-
Put/Call ratio
-
182%
-
Price per share
-
$13.88
-
Number of holders
-
168
-
Value change
-
+$266,710,670
-
Number of buys
-
143
-
Number of sells
-
23
Quarterly Holders Quick Answers
What is CUSIP G1110E107?
CUSIP G1110E107 identifies BHVN - Biohaven Ltd. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP G1110E107:
Institutional Holders of Biohaven Ltd. - Common Shares, no par value (BHVN) as of Q4 2022
As of 31 Dec 2022,
Biohaven Ltd. - Common Shares, no par value (BHVN) was held by
168 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,449,262 shares.
The largest 10 holders included
STIFEL FINANCIAL CORP, STATE STREET CORP, JANUS HENDERSON GROUP PLC, BlackRock Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, RP Management, LLC, ARMISTICE CAPITAL, LLC, FMR LLC, MARSHALL WACE, LLP, and Holocene Advisors, LP.
This page lists
168
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.